Middle East & Africa Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant

Middle East & Africa Pharmaceutical Excipients Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)

The Middle East & Africa pharmaceutical excipients market is expected to grow from US$ 249.21 million in 2022 to US$ 336.74 million by 2028. It is estimated to register a CAGR of 5.1% from 2022 to 2028.

Rising Demand and Emphasis on Co-processed Excipients is fueling the growth of Middle East & Africa Pharmaceutical Excipients Market

Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on the production of co-processed and multifunctional excipients with enhanced performance. Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. The companies are focusing on developing co-processed excipients for drug formulations. For instance, in July 2021, DFE Pharma launched a co-processed excipient, Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). It has been developed as the synergistic solution for challenging oral solid dosage formulations. A co-processed excipient is a promising tool in the production of pharmaceutical products. There is also enough space for the production of new co-processed excipients to satisfy the demand of the pharmaceutical industries, which is expected to act as an opportunity for the growth of the of Middle East & Africa pharmaceutical excipients market during the forecast period.

Market Overview

The Pharmaceutical Excipients market in the Middle East & Africa is further segmented into the UAE, Saudi Arabia, and South Africa. The market is expected to grow due to the huge population base, increase in the prevalence of chronic diseases, and growing research studies across the region. Moreover, surge in the generics and ever-expanding pharmaceutical industry. Saudi Arabia is one of the fastest-growing countries in the Middle East & Africa, whose growth is driven by a huge population base and increasing prevalence of chronic diseases. For instance, according to World Health Organization (WHO), chronic and non-communicable diseases account for more fatalities in Saudi Arabia. It is estimated that by 2030, more than 23 million people will die annually from CVD. Heart disease, stroke, and diabetes alone will reduce gross domestic product from between 1% to 5% in most of the low- and middle-income countries. The affordability and availability of essential medicines for managing common cardiovascular diseases is a key challenge for Saudi Arabia. The prevalence of chronic diseases demands a huge supply of pharmaceutical drugs, and drug manufacturing needs quality excipients. This growing demand for pharmaceutical excipients is boosting the market growth. The demand for cheaper quality excipients from emerging economies such as Saudi Arabia is growing. Hence, the need for functionality excipients is growing across the country, driving the market in the country.

Middle East & Africa Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Pharmaceutical Excipients Market Segmentation

The Middle East & Africa pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the of Middle East & Africa pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

Based on clinical indication, the Middle East & Africa pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the Middle East & Africa pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the Middle East & Africa pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the Middle East & Africa pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the of Middle East & Africa pharmaceutical excipients market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the of Middle East & Africa pharmaceutical excipients market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa pharmaceutical excipients market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution